Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3
Caroline N. Smith(University of Kentucky), Jessica S. Blackburn(University of Kentucky)
Cited by 6
Related Papers
A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)
|Scientific Reports|2021|15
Small Extracellular Vesicles from Radioresistant H3K27M-Pediatric Diffuse Midline Glioma Cells Modulate Tumor Phenotypes and Radiation Response
|bioRxiv (Cold Spring Harbor Laboratory)|2025|1
Small Extracellular Vesicles From Radioresistant H3K27M‐Pediatric Diffuse Midline Glioma Cells Modulate Tumor Phenotypes and Radiation Response
|Journal of Extracellular Vesicles|2025|1
Development and characterization of nanobodies specifically targeting the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3)
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0
Phosphatase activity is dispensable for PRL-3-mediated oncogenesis and tumor progression
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0